StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.44+0.12 (+0.97%)

Close on Nov 18, 2026Market cap $183.19MP/E –Yield –

Korro Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Korro Bio's price to sales ratio was 89.0× on Nov 11, 2026, against 7.3× a year earlier. Over the last 4 years it ranged from 1.2× to 103.5×, with a median of 10.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202689.0×+78.7
2025Dec 31, 202510.2×+7.4
2022Jul 29, 20222.9×+0.0
2021Dec 31, 20212.8×−11.6
2020Dec 31, 202014.4×–

More Korro Bio figures

See a number that looks wrong?